205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
6.98%
Revenue growth above 1.5x NXPI's 3.21%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
11.21%
Gross profit growth above 1.5x NXPI's 0.13%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
25.22%
Positive EBIT growth while NXPI is negative. John Neff might see a substantial edge in operational management.
25.22%
Positive operating income growth while NXPI is negative. John Neff might view this as a competitive edge in operations.
27.21%
Positive net income growth while NXPI is negative. John Neff might see a big relative performance advantage.
30.95%
Positive EPS growth while NXPI is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
28.57%
Positive diluted EPS growth while NXPI is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-1.39%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-1.43%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
0.53%
Dividend growth above 1.5x NXPI's 0.12%. David Dodd would verify if the firm's cash flow is robust enough for these payouts.
70.49%
OCF growth above 1.5x NXPI's 37.88%. David Dodd would confirm a clear edge in underlying cash generation.
90.47%
FCF growth similar to NXPI's 94.26%. Walter Schloss would attribute it to parallel capital spending and operational models.
59.81%
10Y revenue/share CAGR at 75-90% of NXPI's 79.10%. Bill Ackman would press for new markets or product lines to narrow the gap.
96.53%
5Y revenue/share CAGR 1.25-1.5x NXPI's 77.31%. Bruce Berkowitz would verify if cost efficiency or pricing power supports this advantage.
37.60%
Positive 3Y CAGR while NXPI is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
205.28%
10Y OCF/share CAGR above 1.5x NXPI's 104.58%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
226.83%
5Y OCF/share CAGR above 1.5x NXPI's 107.18%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
98.43%
Positive 3Y OCF/share CAGR while NXPI is negative. John Neff might see a big short-term edge in operational efficiency.
-50.56%
Negative 10Y net income/share CAGR while NXPI is at 36.73%. Joel Greenblatt sees a major red flag in long-term profit erosion.
397.85%
5Y net income/share CAGR 1.25-1.5x NXPI's 328.95%. Bruce Berkowitz would check if a better product mix or cost discipline explains the gap.
68.28%
Positive short-term CAGR while NXPI is negative. John Neff would see a clear advantage in near-term profit trajectory.
92.20%
Below 50% of NXPI's 1254.96%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
21.10%
5Y equity/share CAGR 1.25-1.5x NXPI's 18.89%. Bruce Berkowitz confirms if reinvested profits or buybacks explain the superior buildup.
5.44%
Below 50% of NXPI's 42.98%. Michael Burry suspects a serious short-term disadvantage in building book value.
288.56%
Dividend/share CAGR of 288.56% while NXPI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
278.60%
5Y dividend/share CAGR above 1.5x NXPI's 169.49%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
286.61%
3Y dividend/share CAGR above 1.5x NXPI's 20.43%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
6.64%
AR growth well above NXPI's 1.04%. Michael Burry fears inflated revenue or higher default risk in the near future.
1.83%
Inventory growth well above NXPI's 0.47%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-2.11%
Negative asset growth while NXPI invests at 0.28%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-1.74%
We have a declining book value while NXPI shows 3.20%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
-1.63%
Our R&D shrinks while NXPI invests at 4.75%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
1.18%
We expand SG&A while NXPI cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.